MRSA Vaccine Provides Fresh Hope For Widespread Immunity.
American scientists have developed a vaccine that can prevent bacterial infection that leads to the MRSA superbug. Researchers from the University of Rochester in New York decided to create a vaccine for methicillin resistant staph (MRSA) after discovering the rise in MRSA-infected implants in joint replacement patients. The team, led by professor of Orthopaedics from the Musculoskeletal Research, created an antibody that prevents MRSA bacteria from dividing properly. Researchers tested the antibody vaccine prior to the implantation of an MRSA-infected pin to stimulate an infected joint replacement. They monitored the bacterial growth and discovered that the vaccine protected 50% of the implanted pin.
